期刊文献+

血清骨保护素水平与急性脑梗死病因亚型及严重程度的关系 被引量:4

Association of serum osteoprotegerin levels with stroke subtypes and severity in patients with acute ischemic stroke
原文传递
导出
摘要 目的探讨急性脑梗死中血清骨保护素(OPG)水平与病情轻重及梗死灶大小的相关性.及其与脑梗死TOAST病因分型之间的关系。方法选择中国医科大学附属盛京医院神经内科自2010年8月至2011年1月收治的急性脑梗死患者62例(病例组)以及同期健康体检者40例f对照组)为研究对象。依据TOAST分型方法将病例组分为大动脉粥样硬化性卒中(LAA)26例和小动脉闭塞性或腔隙性卒中(SAA)36例。收集各组研究对象的临床资料及相关检查结果,并采用酶联免疫吸附双抗夹心测定法(ELISA法)测定血清OPG水平,以进行统计学分析O结果病例组血清OPG水平明显高于对照组,差异有统计学意义(P〈0.05)。Logistic回归分析显示,高血压和血清OPG水平与急性脑梗死的发生有显著相关性(P=-0.004,P=0.002)。病例组血清OPG水平与美国国立卫生研究院卒中量表(NIHSSl评分和梗死灶最大直径呈相关关系(r=0.658,P=0.000;r=0.487,p=0.010)。LAA组血清OPG水平明显高于SAA组和对照组,差异均有统计学意义(p〈0.05),SAA组与对照组血清OPG水平比较差异无统计学意义胗0.05)。结论血清OPG作为一个独立的危险因素参与急性脑梗死的发病,其水平与病情轻重和梗死灶大小相关,与大动脉粥样硬化性卒中关系更加密切。 Objective To investigate the serum osteoprotegerin (OPG) levels in patients with acute ischemic stroke and evaluate the relation of serum OPG levels with stroke severity, focus size and stroke subtypes according to TOAST criteria. Methods The study consisted of 62 patients with acute cerebral infarction (patient group) and 40 control subjects (control group), collected in our hospital from August 2010 to January 2011. The patient group was sub-divided into large artery atherosclerotic stroke (LAA) group (n=26) and small artery occlusive or lacunar stroke (SAA) group (n=36) in terms of TOAST criteria. Clinical data and examination results were collected. Serum OPG levels were measured with enzyme linked immunoadsorbent assay (ELISA). Results Serum OPG levels in patients with acute ischemic stroke were significantly higher than those in control subjects (P〈0.05); Logistic regression analysis showed that hypertension (P=0.004) and serum OPG levels (P=-0.002) exhibited significant correlations with presence of acute cerebral infarction; serum OPG levels were correlated with NIHSS scores (r=0.658, P=-0.000) and maximum diameter of the focus (r=0.487, /9=-0.010) in ischemic stroke group; serum OPG levels in LAA subgroup were significantly higher than those in SAA subgroup and control group (P〈0.05), and there was no significant difference of serum OPG levels between SAA subgroup and control group (P=0.086). Conclusions Serum OPG levels may play roles in presence of acute ischemic stroke as independent risk factors. OPG levels are related to the severity of illness and focus size, and especially associated with LAA stroke subtype.
作者 王潇 冯娟
出处 《中华神经医学杂志》 CAS CSCD 北大核心 2014年第3期265-268,共4页 Chinese Journal of Neuromedicine
基金 辽宁省科学技术计划重大重点项目(2009225010-2) 沈阳市科学技术计划项目(F11-262-9-20)
关键词 急性脑梗死 骨保护素 TOAST分型 动脉粥样硬化 Acute ischemic stroke Osteoprotegerin TOAST criteria Atherosclerosis
  • 相关文献

参考文献12

  • 1各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33041
  • 2Adams HP Jr,Bendixen BH,Kappelle LJ. Classification of subtype of acute ischemic stroke.Definitions for use in a multicenter clinical trial.TOAST.Trial of Org 10172 in Acute Stroke Treatment[J].STROKE,1993,(01):35-41.
  • 3Schoppet M,Preissner KT,Hofbauer LC. RANK ligand and osteoprotegerin:paracrine regulators of bone metabolism and vascular function[J].Arteriosclerosis Thrombosis and Vascular Biology,2002,(04):549-553.
  • 4Abedin M,Omland T,Ueland T. Relation of osteoprotegerin to coronary calcium and aortic plaque (from the Dallas Heart Study)[J].American Journal of Cardiology,2007,(04):513-518.
  • 5Kiechl S,Schett G,Wenning G. Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease[J].Circulation,2004,(18):2175-2180.
  • 6Oh ES,Rhee E J,Oh KW. Circulating osteoprotegerin levels are associated with age,waist-to-hip ratio,serum total cholesterol,and low-density lipoprotein cholesterol levels in healthy Korean women[J].Metabolism: clinical and experimental,2005,(01):49-54.
  • 7Avignon A,Sultan A,Piot C. Dupuy AM.Osteoprotegerin is associated with silent coronary artery disease in high-risk but asymptomatic type 2 diabetic patients[J].Diabetes Care,2005,(09):2176-2180.
  • 8Kadoglou NP,Gerasimidis T,Golemati S. The relationship between serum levels of vascular calcification inhibitors and carotid plaque vulnerability[J].Journal of Vascular Surgery,2008,(01):55-62.
  • 9Jensen JK,Ueland T,Atar D. Osteoprotegerin concentrations and prognosis in acute ischaemic stroke[J].Journal of Internal Medicine,2010,(04):410-417.
  • 10Guldiken B,Guldiken S,Turgut B. Serum osteoprotegerin levels in patients with acute atherothrombotic stroke and lacunar infarct[J].Thrombosis Research,2007,(04):511-516.

共引文献33040

同被引文献58

  • 1各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33041
  • 2Simonet WS,Lacey DL,Dunstall CR,et al.Osteoprotegerin:a novel secreted protein involved in the regulation of bone density[J].Cell,1997,89(2):309.
  • 3Vidal C,Formosa R,Xuereb-Anastasi A.Functional polymorphisms within the TNFRSF11B(osteoprotegerin)gene increase the risk for low bone mineral density[J].Journal of Molecular Endocrinology,2011,47(3):327-333.
  • 4郏蓉,纪立农.老年人BMD与OPG基因启动子区SNPs及骨代谢生化指标的相关分析研究[D].2011年北京医学会内分泌暨糖尿病学分会学术年会论文集,2011:128-129.
  • 5Roshandel D,Holliday KL,Pye SR,et al.Influence of polymorphisms in the RANKL/RANK/OPG signaling pathway on volumetric bone mineral density and bone geometry at the forearm in men[J].Calcified Tissue International,2011,89(6):446-455.
  • 6Luo Y,Hu Z,Hao J,et al.Significant Associations Between the A163G and G1181C Polymorphisms of the Osteoprotegerin Gene and Risk of Osteoporosis,Especially in Postmenopausal Women:A Meta-Analysis[J].Genetic Testing and Molecular Biomarkers,2014,18(3):211-219.
  • 7Chao TH,Yu HN,Huang CC,et al.Opposite associations of osteoprotegerin and ZBTB40 polymorphisms with bone mineral density of the hip in postmenopausal Taiwan Residents women[J].Journal of the Chinese Medical Association,2012,75(7):335-340.
  • 8Zhang F,He C,Chen G,et al.Association analyses of osteoprotegerin gene polymorphisms withbone mineral density in Chinese postmenopausal women[J].Med Oncol,2013,30(1):389.
  • 9Shen L,Qiu Y,Xing S,et al.Association between osteoprotegerin genetic variants and bone mineral density in Chinese women[J].Int Immunopharmacol,2013,16(2):275-278.
  • 10Wang Q,Chen Z,Huang Y,et al.The relationship between osteoprotegerin gene polymorphisms and bone mineral density in Chinese postmenopausal women[J].Int Immunopharmacol,2013,17(2):404-407.

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部